comprehensive -WSS

comprehensive

author：entertainment 2025-08-15 15:53:16 Page View：4

ASH19 CAR-T — Victor Segura Ibarra and Rita Serda, Ph.D., NCI, NIH

The Food and Drug Administration on Wednesday approved a futuristic new approach to treating cancer, clearing a Novartis therapy that has produced unprecedented results in patients with a rare and deadly cancer. The price tag: $475,000 for a course of treatment.

That sounds staggering to many patients — but it’s far less than analysts expected.

The therapy, called a CAR-T, is made by harvesting patients’ white blood cells and rewiring them to home in on tumors. Novartis’s product is the first CAR-T therapy to come before the FDA, leading a pack of novel treatments that promise to change the standard of care for certain aggressive blood cancers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Senate committee scrutinizes Medicare Advantage brokers
Next article： Moonlake's readout produced a cash windfall. Risks remain

leisure time

At least 13 dead in Texas as scorching temps continue

1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

STAT Summit: Biotech founders on deal

Fromleft,EliLilly'sJacobS.VanNaarden,Avenzo'sAthenaCountouriotis,andBiohaven'sVladCoriconstageatthe2

Apple is now the first public company to be valued at $3 trillion

6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

Future doctors should be trained to promote social change

APStockManyAmericansbelievethatwehavethebesthealthcaresystemintheworld.Yetthatdoesn’tsquarewiththefa

comprehensive

knowledge

leisure time

Future doctors should be trained to promote social change